FI20060188A - Modifioidut IL-4-muteiinin reseptorin antagonistit - Google Patents

Modifioidut IL-4-muteiinin reseptorin antagonistit Download PDF

Info

Publication number
FI20060188A
FI20060188A FI20060188A FI20060188A FI20060188A FI 20060188 A FI20060188 A FI 20060188A FI 20060188 A FI20060188 A FI 20060188A FI 20060188 A FI20060188 A FI 20060188A FI 20060188 A FI20060188 A FI 20060188A
Authority
FI
Finland
Prior art keywords
modified
receptor antagonists
mutein receptor
mutein
antagonists
Prior art date
Application number
FI20060188A
Other languages
English (en)
Swedish (sv)
Inventor
Jeffrey Michael Greve
Clark Pan
Steve Roczniak
Stephanie L Yung
Malinda Longphere
Teresa Mo-Fun Wong
Adrian Tomkinson
Original Assignee
Bayer Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharmaceuticals Corp filed Critical Bayer Pharmaceuticals Corp
Publication of FI20060188A publication Critical patent/FI20060188A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2026—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/45—Toxoplasma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/244—Interleukins [IL]
    • C07K16/247—IL-4

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI20060188A 2003-08-29 2006-02-24 Modifioidut IL-4-muteiinin reseptorin antagonistit FI20060188A (fi)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US49890603P 2003-08-29 2003-08-29
US52822803P 2003-12-09 2003-12-09
US53018203P 2003-12-17 2003-12-17
US10/820,559 US7404957B2 (en) 2003-08-29 2004-04-08 Modified IL-4 mutein receptor antagonists
PCT/US2004/023310 WO2005023860A2 (en) 2003-08-29 2004-07-20 Modified il-4 mutein receptor antagonists

Publications (1)

Publication Number Publication Date
FI20060188A true FI20060188A (fi) 2006-02-24

Family

ID=34280052

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20060188A FI20060188A (fi) 2003-08-29 2006-02-24 Modifioidut IL-4-muteiinin reseptorin antagonistit

Country Status (15)

Country Link
US (1) US7404957B2 (fi)
EP (1) EP1660529A2 (fi)
JP (1) JP4774368B2 (fi)
KR (1) KR20070008505A (fi)
AU (1) AU2004270638B2 (fi)
BR (1) BRPI0413869A (fi)
CA (1) CA2536586A1 (fi)
CZ (1) CZ2006206A3 (fi)
DK (1) DK200600449A (fi)
ES (1) ES2315146A1 (fi)
FI (1) FI20060188A (fi)
IL (1) IL173746A0 (fi)
IS (1) IS8315A (fi)
MX (1) MXPA06002285A (fi)
WO (1) WO2005023860A2 (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7785580B2 (en) * 2003-08-29 2010-08-31 Aerovance, Inc. Modified IL-4 mutein receptor antagonists
KR101241434B1 (ko) * 2004-09-10 2013-03-12 파마오리진 에이피에스 국소 기관, 기관지 또는 폐포의 출혈 또는 객혈의 치료방법
US20070009479A1 (en) * 2005-06-17 2007-01-11 Aerovance, Inc. Methods for treating dermatitis using mutant human IL-4 compositions
KR101566393B1 (ko) * 2005-08-03 2015-11-05 이뮤노젠 아이엔씨 면역접합체 제형
JP2009525267A (ja) * 2006-01-11 2009-07-09 アエロヴァンス インコーポレイティッド ヒトおよび非ヒト霊長類において喘息を処置するための方法および組成物
CA2656135A1 (en) * 2006-07-06 2008-01-10 Apogenix Gmbh Human il-4 muteins in cancer therapy
EA201070129A1 (ru) * 2007-07-11 2010-10-29 Аэрованс, Инк. Фармацевтический сухой порошкообразный аэрозольный состав, включающий полипептид, и способ его приготовления
JP2012520326A (ja) * 2009-03-13 2012-09-06 アエロヴァンス インコーポレイティッド 組換えタンパク質の再生法
WO2011154420A2 (en) 2010-06-08 2011-12-15 Pieris Ag Tear lipocalin muteins binding il-4 r alpha
WO2015000585A1 (en) 2013-07-02 2015-01-08 Walter Sebald Muteins of cytokines of the gamma-chain receptor family conjugated to a non-protein group
RU2758092C1 (ru) * 2018-02-01 2021-10-26 Бэйцзин Кавин Текнолоджи Шеа-Холдинг Ко., Лтд. АНТИТЕЛО К IL-4Rα И ЕГО ПРИМЕНЕНИЕ
EP3553078A1 (en) * 2018-04-11 2019-10-16 Julius-Maximilians-Universität Würzburg Glyco-engineered interleukin-4 based antagonists

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4423131A1 (de) * 1994-07-01 1996-01-04 Bayer Ag Neue hIL-4-Mutantenproteine als Antagonisten oder partielle Agonisten des humanen Interleukin 4
GB9415379D0 (en) * 1994-07-29 1994-09-21 Smithkline Beecham Plc Novel compounds
US5986059A (en) * 1996-06-14 1999-11-16 Bayer Corporation T-cell selective interleukin-4 agonists
US6028176A (en) 1996-07-19 2000-02-22 Bayer Corporation High-affinity interleukin-4 muteins
MY124565A (en) 1996-07-19 2006-06-30 Bayer Corp High-affinity interleukin-4-muteins
DE69838552T2 (de) * 1997-07-14 2008-05-21 Bolder Biotechnology, Inc., Louisville Derivate des wachstumshormons und verwandte proteine
US9303613B2 (en) 2012-02-24 2016-04-05 Ford Global Technologies, Llc Control of vehicle electrical loads during engine auto stop event

Also Published As

Publication number Publication date
AU2004270638A2 (en) 2005-03-17
US20050059590A1 (en) 2005-03-17
IL173746A0 (en) 2006-07-05
IS8315A (is) 2006-02-20
AU2004270638B2 (en) 2010-10-07
ES2315146A1 (es) 2009-03-16
CZ2006206A3 (cs) 2007-01-10
US7404957B2 (en) 2008-07-29
JP4774368B2 (ja) 2011-09-14
BRPI0413869A (pt) 2006-10-24
DK200600449A (da) 2006-03-29
KR20070008505A (ko) 2007-01-17
CA2536586A1 (en) 2005-03-17
AU2004270638A1 (en) 2005-03-17
WO2005023860A2 (en) 2005-03-17
WO2005023860A3 (en) 2005-06-23
EP1660529A2 (en) 2006-05-31
JP2007526757A (ja) 2007-09-20
MXPA06002285A (es) 2007-03-15

Similar Documents

Publication Publication Date Title
FI20060188A (fi) Modifioidut IL-4-muteiinin reseptorin antagonistit
NO20051871D0 (no) Opioid reseptorantagonister
CY2014018I1 (el) Kαρβαμιδο - υποκατεστημενες πυραζολοπυριδινες
ATE413400T1 (de) Cgrp-rezeptorantagonisten
DE602004030930D1 (de) Muscarinische acetylcholin-rezeptor-antagonisten
DK1682142T3 (da) M3-muscarin-acetylcholin-receptor-antagonister
ATE382034T1 (de) Hydroisoindolin-tachykininrezeptorantagonisten
ATE450505T1 (de) Cb 1 rezeptor inversagonisten
DE60327986D1 (de) Sitzstruktur
DE60314931D1 (de) Sitzstruktur
ATE432282T1 (de) 2-alkinyl- und 2-alkenyl-pyrazolo-ä4,3-eü -1,2,4- triazolo-ä1,5-cü -pyrimidinadenosin a2a rezeptorantagonisten
DE50308359D1 (de) Armlehne
DE50308343D1 (de) Armlehne
DE60332816D1 (de) Nk1-antagonisten
NO20043799L (no) 2-oksasolaminer og deres anvendelse som 5-HT2B reseptor antagonister
ATA2792002A (de) Temperaturfühler
DE60328807D1 (de) Chimärer antagonist anth1
FR2840006B1 (fr) Construction demontable
DE10255292B4 (de) Armlehne
TH105710B (th) โอพิออยด์รีเซปเตอร์แอนตะกอนิสต์
EE00339U1 (et) Istumisseade
FIU20030323U0 (fi) Korotuslattiarakenne
UA6902S (uk) Стілець
UA7060S (uk) Стілець
FI20030335A0 (fi) Kaiderakenne